A carregar...

Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects

Recent studies have highlighted the successes of chimeric antigen receptor-modified T- (CART-) cell-based therapy for B-cell malignancies, and early phase clinical trials have been launched in recent years. The few published clinical studies of CART cells in solid tumors have addressed safety and fe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol Res
Main Authors: Guo, Yelei, Wang, Yao, Han, Weidong
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4779545/
https://ncbi.nlm.nih.gov/pubmed/26998495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/3850839
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!